ACO Public Reporting

Medicare Shared Savings Program
Accountable Care Organization
Public Reporting Page

Osler Health participates in the Medicare Shared Savings Program, a program developed by the Centers for Medicare and Medicaid Services (CMS) to provide quality care to Medicare beneficiaries more efficiently and effectively.

ACO Name and Location

Osler Health ACO, LLC
288 Boulevard
Hasbrouck Heights, NJ 07604

ACO Primary Contact
Primary Contact Name James Doulgeris
Primary Contact Phone Number 201-426-6526 ext 710
Primary Contact Email Address

Organizational Information

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Paul Morris N
Clifton Wallington Medical Group N
Amit Tailor N
Denise Daub, MD N
Premier Family Medical, Pc N
Columbus Family Physicians LLC N
Tailor Associates LLC N
Heights Medical Associates PA N
Dr Richard D Santucci DC PA N
Forest Hill Family Health Associates PA N
Immedicenter N
Immedicenter Bloomfield N
James Aversa OD PA N
Jeffrey Rapaport, MD, PA N
Denise Daub N
Immedicenter Totowa N
Riverview Healthcare Associates N
Shirish V Bhatt MD PC N
Lozito Medical Associates PA N
Jerry Jurado MD N
ACO governing body:

Click HERE to view the governing body.

Key ACO clinical and administrative leadership:
James Doulgeris ACO Executive
Nicholas Bonvicino, M.D. Medical Director
Tess Kuczynski Compliance Officer
Taimy Thomas Quality Assurance/Improvement Officer
Associated committees and committee leadership
Committee Name Committee Leader Name and Position
Primary Care Operating and Innovations Amit Tailor, M.D., Chairman
Finance Advisory Shirish Bhatt, M.D., Chairman
Finance James Doulgeris, Chairman
Population and Utilization Management William Glenn, D.O.
Shared Savings Distribution Jan Glowacki, M.D.
Bylaws Paul Morris, D.O.
Physician Credentialing and Review Shirish Bhatt, M.D.
High Risk Member Review Thomas Bellavia, M.D.
Care Coordination Tess Kuczynski
Types of ACO participants, or combinations of participants, that formed the ACO:

Networks of individual practices of ACO professionals

Shared Savings and Losses

  • Amount of Shared Savings/Losses
    • Performance Year 2017, $0

First Agreement Period

Shared Savings Distribution
  • First Agreement Period
    • Performance Year 2017
      • Proportion invested in infrastructure: N/A
      • Proportion invested in redesigned care processes/resources: N/A
      • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2017 Quality Performance Results:

Measure Name Rate ACO Mean
ACO-1: CAHPS: Getting Timely Care, Appointments, and Information 80.52 80.60
ACO-2: CAHPS: How Well Your Providers Communicate 91.58 93.13
ACO-3: CAHPS: Patients’ Rating of Provider 92.22 92.31
ACO-4: CAHPS: Access to Specialists 82.16 83.32
ACO-5: CAHPS: Health Promotion and Education 63.46 62.30
ACO-6: CAHPS: Shared Decision Making 77.70 75.85
ACO-7: CAHPS: Health Status/Functional status 75.50 73.05
ACO-34: CAHPS: Stewardship of Patient Resources 25.21 25.68
ACO-8: Risk Standardized, All Condition Readmission 14.75 15.01
ACO-35: Skilled Nursing Facility 30-Day All-Cause Readmission Measures (SNFRM) 18.92 18.46
ACO-36: All-Cause Unplanned Admissions for Patients with Diabetes 45.82 53.95
ACO-37: All-Cause Unplanned Admissions for Patients with Heart Failure 70.33 79.16
ACO-38: All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions 52.72 61.74
ACO-43: Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91)) 1.41 1.93
ACO-10: Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8) N/A 14.53
ACO-11: Use of Certified EHR Technology 92.11 98.48
ACO-39: Documentation of Current Medications in the Medical Record N/A 87.54
ACO-13: Falls: Screening for Future Fall Risk 38.64 74.38
ACO-14: Preventive Care and Screening: Influenza Immunization 45.41 72.52
ACO-15: Pneumonia Vaccination Status for Older Adults 59.90 72.92
ACO-16: Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up 41.50 70.69
ACO-17: Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention 21.75 90.48
ACO-18: Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan 30.15 61.98
ACO-19: Colorectal Cancer Screening 48.29 64.58
ACO-20: Breast Cancer Screening 52.13 70.05
ACO-21: Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented N/A 76.79
ACO-42: Statin therapy for the Prevention and Treatment of Cardiovascular Disease


ACO-27: Diabetes Mellitus: Hemoglobin A1c Poor Control 31.03 16.74
ACO-41: Diabetes: Eye Exam 41.70 50.37
ACO-28: Hypertension (HTN): Controlling High Blood Pressure 70.94 71.47
ACO-30: Ischemic Vascular Disease (IVD): Use of Aspirin or Another Antithrombotic 48.63 86.86
ACO-31: Heart Failure (HF): Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD) N/A 88.67
ACO-33: Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy – for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%) N/A 79.67

Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Osler Health ACO, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A32693 in the public use files on

Payment Rule Waivers

No, our ACO does not use the SNF 3-Day Rule Waiver.